Piramal Enterprises Ltd
NSE:PEL
Intrinsic Value
Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. [ Read More ]
The intrinsic value of one PEL stock under the Base Case scenario is 1 124.07 INR. Compared to the current market price of 913.05 INR, Piramal Enterprises Ltd is Undervalued by 19%.
Valuation Backtest
Piramal Enterprises Ltd
Run backtest to discover the historical profit from buying and selling PEL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Piramal Enterprises Ltd
Current Assets | 53.3B |
Cash & Short-Term Investments | 39.2B |
Receivables | 14.2B |
Non-Current Assets | 763.1B |
Long-Term Investments | 213B |
PP&E | 5.6B |
Intangibles | 1.8B |
Other Non-Current Assets | 542.7B |
Current Liabilities | 10.2B |
Accounts Payable | 4.3B |
Other Current Liabilities | 5.9B |
Non-Current Liabilities | 519.1B |
Long-Term Debt | 498B |
Other Non-Current Liabilities | 21.1B |
Earnings Waterfall
Piramal Enterprises Ltd
Revenue
|
80B
INR
|
Cost of Revenue
|
-42.2B
INR
|
Gross Profit
|
37.8B
INR
|
Operating Expenses
|
-28.7B
INR
|
Operating Income
|
9.1B
INR
|
Other Expenses
|
-29.3B
INR
|
Net Income
|
-20.2B
INR
|
Free Cash Flow Analysis
Piramal Enterprises Ltd
PEL Profitability Score
Profitability Due Diligence
Piramal Enterprises Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Piramal Enterprises Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
PEL Solvency Score
Solvency Due Diligence
Piramal Enterprises Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Piramal Enterprises Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PEL Price Targets Summary
Piramal Enterprises Ltd
According to Wall Street analysts, the average 1-year price target for PEL is 1 009.07 INR with a low forecast of 782.75 INR and a high forecast of 1 312.5 INR.
Shareholder Return
PEL Price
Piramal Enterprises Ltd
Average Annual Return | -7.21% |
Standard Deviation of Annual Returns | 62.7% |
Max Drawdown | -72% |
Market Capitalization | 205.2B INR |
Shares Outstanding | 223 482 800 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. The company is headquartered in Mumbai, Maharashtra and currently employs 13,561 full-time employees. PEL’s financial services offer a range of financial products and solutions, with wholesale and retail financing. The wholesale lending business provides financing to real estate developers, as well as corporate. Within retail lending, PEL is engaged in building a multi-product platform and offers home loans, loans for small businesses and loans for working capital to its customers. The firm offers India Resurgence Fund (IndiaRF), the distressed asset investing platform, which invests in equity and/or debt across non-real estate sectors. Its financial services also include alternative assets and investments in Shriram Group. PEL has a differentiated business model that is diversified across three segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generics (CHG), and India Consumer Healthcare.
Contact
IPO
Employees
Officers
The intrinsic value of one PEL stock under the Base Case scenario is 1 124.07 INR.
Compared to the current market price of 913.05 INR, Piramal Enterprises Ltd is Undervalued by 19%.